| 영문 | toxin | 한글 | 독소 |
|---|---|---|---|
| 설명 | 생물체가 만들어내는 독성과 항원성을 가진 물질. 독소를 적당한 동물에 주사하면 항체인 항독소가 생성되고, 이 항독소와 독소는 특이적으로 결합한다. 세균에 의한 단백분해산물로 맹독성을 발휘나는 것에 아민이 있으나, 이것에는 항원성이 없으므로 독소가 아니다. 일반적으로 중독증상을 발현하는데 일정한 시간이 걸리며, 동물에 따라 감수성이 다른 점이 독물과 다르다. 독소에는 생물체 안에 만들어져 남아 있다가 생물체가 파괴되었을 때 독성을 갖는 내독소(endotoxins)와 생물체가 주변으로 물질을 분비하는 외독소(exotoxins)가 있다. 독소를 내는 생물체에 따라 세균성 독소 외에 동물성 독소 및 식물성 독소가 있다. 동물성 독소는 대부분 독선에서 분비되며, 뱀-전갈-거미-벌 등이 대표적인 것이다. 식물성 독소로는 리신(ricin)-아브린(abrin)-로비닌(robinin)-크로틴(crotin) 등이 있다. 세균은 인체에 영향을 미쳐 디프테리아-파상풍-성홍열-가스괴저 등을 일으키고, 또 어떤 세균과 버섯류는 생장할 때 독소를 분비, 이것을 먹으면 보툴리누스 중독-맥각 중독 등을 일으킨다. 그 밖에 물고기에도 독성을 가진 것이 있다. 인체에는 독소가 들어왔을 때 그와 결합하여 독성을 해독시키는 항독소가 혈청-림프액 등에 생긴다. |
||
| TAT | 1) Thematic Apperception Test; 주제 통각 검사 2) (Equine) Tetanus Anti-Toxin; 항... |
|---|---|
| CT | calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ... |
| ET | educational therapy; effective temperature; ejection time; embryo transfer; endothelin; endotoxin; e... |
| APSGN | Acute Post-Streptococcal Glomerulo-Nephritis; 연쇄상 구균감염후 급성 사구체 신염 |
| PSGN | Post-Streptococcal Glomerulo-Nephritis |
| GAS | Group A Streptococcal |
|---|---|
| GABHS | Group A beta hemolytic streptococcal |
| GBS | Group B Streptococcal |
| PSGN | Post-streptococcal glomerulonephritis |
| STSS | Streptococcal Toxic Shock Syndrome |
| streptococcal toxins | Group of haemolytic exotoxins released by Streptococci. _ haemolysin: 26-39 Kd (four types), forms ring like structures in membranes (see Streptolysin O). Lipid target unclear. _ haemolysin: a hot cold haemolysin with sphingomyelinase C activity. _ haemolysin: complex of two proteins (29 and 26 kD) that act synergistically, rabbit erythrocytes particularly sensitive. _ toxin: heat stable peptide (5 kD) with high proportion of hydrophobic amino acids. Seems to act in a detergent like manner (c.f. Subtilysin), but may form hydrophilic transmembrane pores by cooperative interaction with other _ toxin molecules. Leucocidin (Panton Valentine leucocidin): two components f (fast migration on CM cellulose column: 32 kD) and s (slow: 38 kD). Mode of action contentious. See: Streptococcus, streptolysins O and S, erythrogenic toxin. (18 Nov 1997) |
|---|
| acute post-streptococcal glomerulonephritis | <nephrology> A disease of the kidneys that results in inflammation of the glomerulus (the portion of the kidney that filters the blood). Conditions which may cause glomerulonephritis include post-streptococcal disease (strep throat), lupus, syphilis, bacterial endocarditis, membranoproliferative glomerulonephritis, sepsis, vasculitis, Goodpasture's syndrome, typhoid fever, Henoch-Schonlein purpura, hepatitis or a viral infection (for example mumps, measles, mononucleosis). (27 Sep 1997) |
|---|---|
| group A streptococcal necrotizing fasciitis | A complication of infection with GAS (group A streptococci) in which the bacteria attacks and destroys muscle tissue. According to the CDC, 5-10% of people with severe GAS infection develop necrotizing fasciitis. Though the infection can be treated with antibiotics, the fatality rate is close to 30%. This complication often develops as a wound infection after surgery or injury. (05 Mar 2000) |
| streptococcal | Relating to or caused by any organism of the genus Streptococcus. (05 Mar 2000) |
| streptococcal fibrinolysin | <enzyme> Plasminogen activator released by Streptococcus pyogenes. Occurs in two forms, A and B. (18 Nov 1997) |
| streptococcal infections | Infections with bacteria of the genus streptococcus. (12 Dec 1998) |
| streptococcal lymphadenitis | A contagious bacterial disease of pigs caused by a group E streptococcus and characterised by the formation of abscesses in the cervical and/or cephalic lymph nodes. (05 Mar 2000) |
| streptococcal nuclease | <enzyme> From streptococcus haemolyticus; degrades RNA and DNA producing oligonucleotides terminating in 5'-phosphate Registry number: EC 3.1.30.- (26 Jun 1999) |
| streptococcal pneumonia | Pneumonia due to Streptococcus pyogenes. (05 Mar 2000) |
| animal toxin | <pharmacology> Any poisonous substance (including but not limited to venom) produced by an animal. (11 May 1997) |
| anthrax toxin | A culture filtrate of Bacillus anthracis containing an exotoxin with at least three different antigenically distinct components: oedema factor, lethal factor, and protective antigen. Synonym: Bacillus anthracis toxin. (05 Mar 2000) |
| Bacillus anthracis toxin | A culture filtrate of Bacillus anthracis containing an exotoxin with at least three different antigenically distinct components: oedema factor, lethal factor, and protective antigen. Synonym: Bacillus anthracis toxin. (05 Mar 2000) |
| bacterial toxin | Any intracellular or extracellular toxin formed in or elaborated by bacterial cells. (05 Mar 2000) |
| bee toxin | The toxin delivered by a bee sting; contains three active principles: biogenic amines, active peptides, and certain hydrolytic enzymes. (05 Mar 2000) |
| botulinum toxin | <protein> Neurotoxin (50 kD, 7 distinct serotypes) produced by certain strains of Clostridium botulinum. The bacterium produces the toxin as a complex with a haemagglutinin that prevents toxin inactivation in the gut. Proteolysis in the body results in cleavage into two fragments A and B. B binds to gangliosides and may stimulate the endocytosis of fragment A. See: synaptobrevin, tetanus toxin. (18 Nov 1997) |
| botulinum toxin type a | <chemical> A neurotoxin produced by clostridium botulinum. When consumed in contaminated food it can cause paralysis and death. In its purified form, it has been used in the treatment of blepharospasm and strabismus. Pharmacological action: neuromuscular agents. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|